Abstract
Severe symptomatic aortic stenosis in a 90-year-old man was treated with percutaneous aortic valve implantation (TAVI) with a 29-mm CoreValve Revalving™ system. Following implantation, severe aortic regurgitation occurred. Echocardiography showed a small paravalvular and a huge valvular leakage, probably due to one malfunctioning valve leaflet. Concerning this pathophysiology, a further TAVI was performed using a second 29-mm CoreValve Revalving™ system, as a “valve-in-valve” implantation.
This is a preview of subscription content, log in via an institution to check access.
References
Bojara W, Mumme A, Gerckens U, Lindstaedt M, Gotzmann M, Germing A, Fritz M, Pennekamp W, Mugge A (2009) Implantation of the CoreValve self-expanding valve prosthesis via a subclavian artery approach: a case report. Clin Res Cardiol 98:201–204
Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB (2002) Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106:3006–3008
Grube E, Buellesfeld L, Mueller R, Sauren B, Zickmann B, Nair D, Beucher H, Felderhoff T, Iversen S, Gerckens U (2008) Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Intervent 1:167–175
Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, Mueller R, Menichelli M, Schmidt T, Zickmann B, Iversen S, Stone GW (2006) Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 114:1616–1624
Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R (2007) Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 50:69–76
Hammerstingl C, Werner N, Nickenig G (2009) Symptomatic paravalvular leakage after mechanical aortic valve replacement in a critically ill patient: why not just “plug” the hole? Eur J Echocardiogr 10:576–578
Piazza N, Grube E, Gerckens U, den Heyer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde F, de Jaegere P, Serruys PW (2008) Prodedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18F) CoreValve Revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervent 4:242–249
Piazza N, Schultz C, de Jaegere PP, Serruys PW (2009) Implantation of two self-expanding aortic bioprosthetic valves during the same procedure-insights into valve-in-valve implantation (“Russian doll concept”). Catheter Cardiovasc Interv 73:530–539
Ruiz CE, Laborde JC, Condado JF, Chiam PT, Condado JA (2008) First percutaneous transcatheter aortic valve-in-valve implant with three year follow-up. Catheter Cardiovasc Interv 72:143–148
Shapira Y, Hirsch R, Kornowski R, Hasdai D, Assali A, Vaturi M, Sievert H, Hein R, Battler A, Sagie A (2007) Percutaneous closure of perivalvular leaks with Amplatzer occluders: feasibility, safety, and shortterm results. J Heart Valve Dis 16:305–313
Svensson LG, Dewey T, Kapadia S, Roselli EE, Stewart A, Williams M, Anderson WN, Brown D, Leon M, Lytle B, Moses J, Mack M, Tuzcu M, Smith C (2008) United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg 86:46–54
Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A (2007) Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 28:230–268
Walther T, Falk V, Borger MA, Dewey T, Wimmer-Greinecker G, Schuler G, Mack M, Mohr FW (2007) Minimally invasive transapical beating heart aortic valve implantation–proof of concept. Eur J Cardiothorac Surg 31:9–15
Walther T, Falk V, Kempfert J, Borger MA, Fassl J, Chu MW, Schuler G, Mohr FW (2008) Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur J Cardiothorac Surg 33:983–988
Webb JG, Altwegg L, Boone RH, Cheung A, Ye J, Lichtenstein S, Lee M, Masson JB, Thompson C, Moss R, Carere R, Munt B, Nietlispach F, Humphries K (2009) Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 119:3009–3016
Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, Sinhal A, Carere RG, Munt B, Ricci D, Ye J, Cheung A, Lichtenstein SV (2007) Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 116:755–763
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zahn, R., Schiele, R., Kilkowski, C. et al. Severe aortic regurgitation after percutaneous transcatheter aortic valve implantation: on the importance to clarify the underlying pathophysiology. Clin Res Cardiol 99, 193–197 (2010). https://doi.org/10.1007/s00392-009-0102-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-009-0102-5